ADVERTISEMENT
  • The Membership Club
  • #EndSARS Dashboard
  • PT Hausa
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
Wednesday, May 25, 2022
Premium Times Nigeria
  • Home
  • Gender
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • COVID-19
    • News Reports
    • Special Reports and Investigations
    • Data and Infographics
    • Health Specials
    • Features and Interviews
    • Multimedia
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Special Reports/Investigations
    • Data and Infographics
    • Features and Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • #EndSARS Dashboard
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • #PandoraPapers
  • AUN-PT Data Hub
  • Home
  • Gender
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • COVID-19
    • News Reports
    • Special Reports and Investigations
    • Data and Infographics
    • Health Specials
    • Features and Interviews
    • Multimedia
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Special Reports/Investigations
    • Data and Infographics
    • Features and Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • #EndSARS Dashboard
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • #PandoraPapers
  • AUN-PT Data Hub
Premium Times Nigeria
BUA Group Ad BUA Group Ad BUA Group Ad
ADVERTISEMENT
COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]

COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]

Another COVID-19 vaccine shows nearly 95% protection

U.S. drugmaker, Moderna, plans to apply for approval to use the vaccine in the next few weeks.

byNike Adebowale
November 16, 2020
2 min read

A US drugmaker, Moderna, on Monday announced that its coronavirus vaccine is 94.5 per cent effective, based on an early look at the results from its large, continuing study.

The Chief Executive of Moderna, Stéphane Bancel, said the results had provided “the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease.”

The announcement is coming barely a week after drug giant Pfizer and German biotechnology firm BioNTech, announced the development of an experimental coronavirus vaccine which prevented more than 90 per cent of infections in a study of tens of thousands of volunteers.

Scientists across the world are racing to develop vaccines and effective treatments against the surging coronavirus pandemic, which has infected more than 50 million people, killing over a million persons in at least 200 countries where it has spread, according to data from worldometer.com.

There are no proven, knockout treatments for the coronavirus yet and U.S. health officials say a vaccine could take at least a year.

According to a report on BBC, Moderna plans to apply for approval to use the vaccine in the next few weeks.

“I had been saying I would be satisfied with a 75 percent effective vaccine. Aspirationally, you would like to see 90, 95 percent, but I wasn’t expecting it. I thought we’d be good, but 94.5 percent is very impressive,” said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases in the U.S.

The report indicates that the vaccine trial involved 30,000 people in the U.S. with half being given two doses of the vaccine, four weeks apart.

The rest had dummy injections and the analysis was based on the first 95 to develop COVID-19 symptoms.

Only five of the COVID-19 cases were in people given the vaccine, 90 were in those given the dummy treatment.

Data also shows there were 11 cases of severe COVID-19 in the trial, but none happened in people who were immunised.

ALSO READ: Amid second wave of coronavirus, Pfizer’s vaccine promises over 90% protection

“The overall effectiveness has been remarkable… it’s a great day,” Tal Zaks, the chief medical officer at Moderna, told BBC News.

Developing Vaccines

The World Health Organisation (WHO) is coordinating global efforts to develop a vaccine, in a bid to deliver two billion doses by the end of 2021.

Pfizer and Moderna were the first to announce early data on large studies, but 10 other companies are also conducting big Phase 3 trials in a global race to produce a vaccine, including efforts in Australia, Britain, China, India and Russia. More than 50 other candidates are in earlier stages of testing.

The U.S. Food and Drug Administration has said that coronavirus vaccines should be at least 50 per cent effective to be approved.

  • WhatsApp
  • Tweet
  • Email
  • Print
  • Telegram
  • More
  • Share on Tumblr
  • Pocket

WATCH: Governor Yahaya Bello's Roadmap to Hope 2023

CITIZEN-FM AD


Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


TEXT AD: Why women cheat: what every Nigerian man should know







PT Mag Campaign AD

Previous Post

Buhari’s N-Power, Anchor Borrowers Programme has made little impact — Ndume

Next Post

INVESTIGATION: Authority Stealing: How Fashola’s ministry illegally paid ₦4.6BN into officials‘ personal accounts

Nike Adebowale

Nike Adebowale

Nike Adebowale covers the health beat.  She holds a degree from Ekiti State University, Ado Ekiti. Twitter: @nikeadebowale1 

More News

Senator Ike Ekweremadu

BREAKING: Ekweremadu withdraws from PDP primaries, may join APC

May 25, 2022
sanitary pads used to illustrate the tory. [PHOTO CREDIT: Saathi Pads]

Menstrual Hygiene: Nigerian government departments, agencies open pad banks in offices

May 25, 2022
Nigeria-Police

Two catholic priests, two other persons abducted in Katsina

May 25, 2022
Bukola Saraki [Photo: @bukola.saraki]

INTERVIEW: What I will do as president on state police, crypto, repentant terrorists – Saraki

May 25, 2022
APC and PDP

ANALYSIS: Lagos 2023: APC, PDP set for guber primaries but age-old issues remain

May 25, 2022
Floor of the Nigerian Stock Exchange

Nigerian stocks in biggest year-to-date fall after interest rate increase

May 24, 2022
Next Post
Minister of Works and Housing Mr Babatunde Fashola SAN making a point during a Press Briefing on the Partial Closure for Repairs and Restoration of the Third Mainland Bridge in Lagos at the Ministry of Works and Housing Headquarters Mabushi Abuja on Tuesday 21st July 2020 [PHOTO CREDIT: worksandhousing]

INVESTIGATION: Authority Stealing: How Fashola's ministry illegally paid ₦4.6BN into officials‘ personal accounts

Market women used to illustrate the story. [Photo credit: Around the World in 80 Clicks]

Food prices highest in Kwara, Edo, Sokoto in October - NBS

Leave Comment

Search

AUN-PT Ad





Transport-Technology


Stanbic Ad


Access Bank Ad





Glo Ad


Subscribe to News via Email

Enter your email address and receive notifications of news by email.

Join 1,847,098 other subscribers.

Advertisement






netherland biz school Advert



Zenith Advert

ADVERTISEMENT

Our Digital Network

  • PT Hausa
  • Election Centre
  • Human Trafficking Investigation
  • Centre for Investigative Journalism
  • National Conference
  • Press Attack Tracker
  • PT Academy
  • Dubawa
  • LeaksNG
  • Campus Reporter

Resources

  • Oil & Gas Facts
  • List of Universities in Nigeria
  • LIST: Federal Unity Colleges in Nigeria
  • NYSC Orientation Camps in Nigeria
  • Nigeria’s Federal/States’ Budgets since 2005
  • Malabu Scandal Thread
  • World Cup 2018
  • Panama Papers Game
  • Our Digital Network
  • About Us
  • Resources
  • Projects
  • Data & Infographics
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

No Result
View All Result
  • #PandoraPapers
  • Gender
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Health
    • COVID-19
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Investigations
    • Investigations
    • Interviews
    • Multimedia
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • #EndSARS Dashboard
  • Projects
    • Panama Papers
    • Paradise Papers
    • Parliament Watch
    • AGAHRIN
  • AUN-PT Data Hub
  • Opinion
  • The Membership Club
  • Dubawa
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

Our website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.